Chlordiazepoxide: Affected lot may be OOS
Last updated
Summary
Product
Chlordiazepoxide
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Chlordiazepoxide |
Chlordiazepoxide 10mg |
DIN 00522988 |
Capsule |
Chlordiazepoxide hydrochloride 10mg |
TF9331 |
Chlordiazepoxide |
Chlordiazepoxide 5mg |
DIN 00522724 |
Capsule |
Chlordiazepoxide hydrochloride 5mg |
PX9570, TD4569 |
Issue
Affected lot may be OOS for related compound CZ RC1
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Distributors
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
AA Pharma Inc. 1165 Creditstone Road Unit #1, Vaughan, Ontario, Canada |
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type III
Identification number
RA-74313
Get notified
Receive notifications for new and updated recalls and alerts by category.